サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1539298

経カテーテル心臓弁置換・修復市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年

Transcatheter Heart Valve Replacement Repair Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 231 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
経カテーテル心臓弁置換・修復市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年
出版日: 2024年08月20日
発行: Persistence Market Research
ページ情報: 英文 231 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、世界の経カテーテル心臓弁置換・修復（TAVR）市場に関する詳細な調査レポートを出版し、促進要因・動向・機会・課題などの市場ダイナミクスに関する詳細な考察を提供しました。当レポートは、特に心血管医療機器業界の利害関係者向けに、市場構造と将来展望の包括的な理解を提供することを目的としています。

主要な洞察

  • 世界市場収益（2022年）：84億米ドル
  • 推定市場金額（2033年）：255億米ドル
  • 世界市場成長率（CAGR 2022年～2033年）：13.1%

TAVRの世界市場 - レポート範囲：

TAVR市場は、特に重度の大動脈弁狭窄症やその他の心血管系疾患を患う患者の心臓弁の交換や修復に使用される機器や技術の生産と流通に焦点を当てています。この市場は、心血管疾患の有病率の増加、低侵襲手技の採用拡大、TAVR製品の継続的な技術進歩によって促進されています。

市場成長の促進要因：

TAVR製品の継続的な技術進歩と心血管疾患の有病率の増加

TAVR市場の主要な促進要因の1つは、経カテーテル大動脈弁置換術（TAVR）デバイスの継続的な技術進歩です。各社は、重度の大動脈弁狭窄症患者の免疫拒絶反応を軽減するため、耐久性を高めた第2世代のTAVRデバイスを開発しています。これらの新しいデバイスは、最近のいくつかの研究で証明されているように、傍弁逆流、弁塞栓、その他の出血事象の発生率の低下など、安全性に大きな利点をもたらしています。

高度な画像技術もまた、TAVR手技中の意思決定を改善する上で重要な役割を果たしています。こうした技術革新は、TAVI（経カテーテル大動脈弁植え込み術）やTAVR製品の今後の成長を促進する継続的な技術開発により、市場が繁栄する有利な機会を生み出すと期待されています。

心血管疾患（CVD）の有病率の上昇は、TAVR市場の成長を促進するもう一つの重要な要因です。世界保健機関（WHO）によると、心血管疾患は世界の死因の第1位であり、年間推定死亡者数は1,790万人です。心臓発作と脳卒中がCVDによる死亡者5人中4人以上を占める中、TAVRのような効果的な弁置換手術に対する需要は増加し、市場拡大の促進力になると予想されます。

市場の課題

高コストと規制上の課題

有望な成長見通しにもかかわらず、TAVR市場はいくつかの課題に直面しています。特にヘルスケア予算が限られている低・中所得国では、TAVRの手技とデバイスの高額な費用が普及の大きな障壁となる可能性があります。さらに、TAVRデバイスの規制状況は複雑で、新製品を市場に投入する前に厳しい承認プロセスが必要です。こうした規制上の課題を克服するには時間とコストがかかるため、市場の成長が鈍化する可能性があります。

さらに、技術の進歩が市場を前進させる一方で、研究開発への多額の投資も必要となります。企業は競争力を維持するために継続的な技術革新を行わなければならず、特に市場規模の小さい企業にとっては、リソースを圧迫し収益性に影響を与える可能性があります。

本レポートで扱う主要な質問

  • 世界のTAVR市場の成長を促す主要な要因は何か？
  • TAVRの採用を促進している消費者層は？
  • 技術の進歩は競合情勢にどのような影響を与えているか？
  • 世界のTAVR市場における主要企業はどこか、また、市場ポジションを維持するためにどのような戦略を採用しているか？
  • 世界のTAVR市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限
  • 包含事項・除外事項

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 製品イノベーション / 開発動向

第4章 主要な成功要因

  • 採用率 / 使用状況分析 - 地域別
  • 技術評価
  • 製品のUSP分析
  • 規制シナリオ
  • 疾病疫学
  • 償還の情勢
  • 最近の製品承認 / 発売
  • PESTEL分析
  • ポーターの分析
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別
    • 適応症別
    • エンドユーザー別
    • 地域別
  • 2024年の市場シナリオ

第7章 世界市場の需要（金額10億米ドル）分析

  • 過去の市場金額（10億米ドル）分析、2019年～2023年
  • 現在および将来の市場金額（10億米ドル）の分析と予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対額の機会分析

第8章 世界市場分析：製品別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（10億米ドル）分析：製品別、2019年～2023年
  • 現在および将来の市場規模（10億米ドル）の分析と予測：製品別、2024年～2033年
    • 経カテーテル大動脈弁置換術（TAVR）デバイス
    • 経カテーテル僧帽弁修復（TMVR）デバイス
  • 市場の魅力分析：製品別

第9章 世界市場分析：適応症別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（10億米ドル）分析：適応症別、2019年～2023年
  • 現在および将来の市場規模（10億米ドル）の分析と予測：適応症別、2024年～2033年
    • 重度の大動脈弁狭窄症
    • バルブインバルブ手術（生体弁不全）
    • 大動脈弁逆流症
  • 市場の魅力分析：適応症別

第10章 世界市場分析：エンドユーザー別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（10億米ドル）分析：エンドユーザー別、2019年～2023年
  • 現在および将来の市場規模（10億米ドル）の分析と予測：エンドユーザー別、2024年～2033年
    • 病院
    • 独立した心臓カテーテル検査室
    • 外来手術センター
  • 市場の魅力分析：エンドユーザー別

第11章 世界市場分析：地域別

  • イントロダクション
  • 過去の市場規模（10億米ドル）の分析：地域別、2019年～2023年
  • 現在および将来の市場規模（10億米ドル）の分析と予測：地域別、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ（MEA）
  • 市場の魅力分析：地域別

第12章 北米市場分析

第13章 ラテンアメリカ市場分析

第14章 欧州市場分析

第15章 東アジア市場分析

第16章 南アジア市場分析

第17章 オセアニア市場

第18章 中東・アフリカ（MEA）市場分析

第19章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細情報
    • Abbott
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Boston Scientific Corporation
    • JenaValve Technology, Inc.
    • Meril Life Sciences
    • Sahajanand Medical Technologies Limited
    • MicroPort Scientific Corporation
    • Venus Medtech（Hangzhou）Inc.
    • Suzhou Jiecheng Medical Technology Co. Ltd.
    • Peijia Medical Limited
    • Blue Sail Medical Co., Ltd.

第21章 使用される前提条件と頭字語

第22章 調査手法

目次
Product Code: PMRREP11167

Persistence Market Research has recently published an in-depth report on the global transcatheter heart valve replacement and repair (TAVR) market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a comprehensive understanding of the market structure and future outlook, particularly for stakeholders in the cardiovascular medical device industry.

Key Insights:

  • Global Market Revenue (2022): US$ 8.4 Billion
  • Estimated Market Value (2033): US$ 25.5 Billion
  • Global Market Growth Rate (CAGR 2022-2033): 13.1%

Global TAVR Market - Report Scope:

The TAVR market focuses on the production and distribution of devices and technologies used in the replacement and repair of heart valves, particularly for patients suffering from severe aortic stenosis and other cardiovascular diseases. This market is driven by the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, and continuous technological advancements in TAVR products.

Market Growth Drivers:

Continuous Technological Advancements in TAVR Products Coupled with Increasing Prevalence of Cardiovascular Diseases

One of the primary drivers of the TAVR market is the continuous technological advancements in transcatheter aortic valve replacement (TAVR) devices. Companies are developing second-generation TAVR devices with enhanced durability to reduce immune rejections in patients with severe aortic stenosis. These newer devices offer significant safety benefits, including lower rates of paravalvular regurgitation, valve embolization, and other bleeding events, as evidenced by several recent studies.

Advanced imaging technologies are also playing a crucial role in improving decision-making during TAVR procedures. These innovations are expected to create lucrative opportunities for the market to flourish, with ongoing technological developments driving future growth in TAVI (transcatheter aortic valve implantation) and TAVR products.

The rising prevalence of cardiovascular diseases (CVDs) is another significant factor fueling the growth of the TAVR market. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths per year. With heart attacks and strokes making up more than four out of every five CVD deaths, the demand for effective valve replacement surgeries, such as TAVR, is expected to rise, driving market expansion.

Market Challenges:

High Costs and Regulatory Challenges

Despite the promising growth prospects, the TAVR market faces several challenges. The high cost of TAVR procedures and devices can be a significant barrier to widespread adoption, particularly in low- and middle-income countries where healthcare budgets are limited. Additionally, the regulatory landscape for TAVR devices is complex, with stringent approval processes required before new products can be introduced to the market. Navigating these regulatory challenges can be time-consuming and costly, potentially slowing down market growth.

Furthermore, while technological advancements are driving the market forward, they also require substantial investment in research and development. Companies must continuously innovate to stay competitive, which can strain resources and impact profitability, particularly for smaller players in the market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global TAVR market?
  • Which consumer segments are leading the adoption of TAVR procedures?
  • How are technological advancements influencing the competitive landscape?
  • Who are the key players in the global TAVR market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the global TAVR market?

Competitive Intelligence and Business Strategy:

Leading players in the global TAVR market, including Edwards Lifesciences, Medtronic, and Boston Scientific Corporation, are focusing on product innovation, strategic partnerships, and expanding their market presence in emerging economies. These companies are heavily investing in research and development to create next-generation TAVR devices that offer improved safety, durability, and patient outcomes. Collaborations with healthcare providers and academic institutions are enhancing market credibility and driving the adoption of new technologies.

Additionally, the market is seeing a trend towards the integration of advanced imaging and diagnostic tools with TAVR procedures, further improving the precision and outcomes of valve replacement surgeries. As the market continues to grow, companies are expected to explore new opportunities in minimally invasive cardiovascular procedures and expand their product portfolios to cater to a broader patient population.

Key Companies Profiled:

  • Abbott
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Boston Scientific Corporation
  • JenaValve Technology, Inc.
  • Meril Life Sciences
  • Sahajanand Medical Technologies Limited
  • MicroPort Scientific Corporation
  • Venus Medtech (Hangzhou) Inc.
  • Suzhou Jiecheng Medical Technology Co. Ltd.
  • Peijia Medical Limited
  • Blue Sail Medical Co., Ltd.

Key Segments Covered in Transcatheter Heart Valve Replacement Repair Industry Research

Product:

  • Transcatheter Aortic Valve Replacement (TAVR)
  • Transcatheter Mitral Valve Repair (TMVR)

Indication:

  • Severe Aortic Valve Stenosis
  • Valve-in-Valve Procedures (Failed Bioprosthesis)
  • Aortic Regurgitation

End User:

  • Hospitals
  • Independent Cardiac Catheterization Labs
  • Ambulatory Surgical Centres

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Adoption Rate/Usage Analysis - By Region
  • 4.2. Technology Assessment
  • 4.3. Product USP Analysis
  • 4.4. Regulatory Scenario
  • 4.5. Disease Epidemiology
  • 4.6. Reimbursement Landscape
  • 4.7. Recent Product Approvals/Launches
  • 4.8. PESTEL Analysis
  • 4.9. Porter's Analysis
  • 4.10. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Cardiac Surgery Devices Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Prevalence of Cardiovascular Diseases
    • 5.2.2. Demand for Minimally Invasive Procedures
    • 5.2.3. Growing Number of Patients Suffering from Aortic Stenosis
    • 5.2.4. Increasing Product Approvals
    • 5.2.5. Technological Advancements
    • 5.2.6. Prevalence of Obesity
    • 5.2.7. Increasing Surgical Procedural Volume
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Indication
    • 6.1.3. By End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis, by Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2024-2033
    • 8.3.1. Transcatheter Aortic Valve Replacement (TAVR) Devices
      • 8.3.1.1. Self - Expandable Transcatheter Aortic Valves
      • 8.3.1.2. Balloon-Expandable Transcatheter Aortic Valves
      • 8.3.1.3. "Mechanically Expanded Transcatheter Aortic Valves"
    • 8.3.2. Transcatheter Mitral Valve Repair (TMVR) Devices
  • 8.4. Market Attractiveness Analysis, by Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Indication, 2024-2033
    • 9.3.1. Severe Aortic Valve Stenosis
    • 9.3.2. Valve-in-Valve Procedures (Failed Bioprosthesis)
    • 9.3.3. Aortic Regurgitation
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Independent Cardiac Catheterization Labs
    • 10.3.3. Ambulatory Surgical Centers
  • 10.4. Market Attractiveness Analysis, by End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis, by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Indication
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Indication
    • 12.4.4. By End User
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. U.S. Market Analysis
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.1.2.1. By Product
        • 12.7.1.2.2. By Indication
        • 12.7.1.2.3. By End User
    • 12.7.2. Canada Market Analysis
      • 12.7.2.1. Introduction
      • 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.2.2.1. By Product
        • 12.7.2.2.2. By Indication
        • 12.7.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Indication
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Country Level Analysis & Forecast
    • 13.7.1. Mexico Market Analysis
      • 13.7.1.1. Introduction
      • 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.1.2.1. By Product
        • 13.7.1.2.2. By Indication
        • 13.7.1.2.3. By End User
    • 13.7.2. Brazil Market Analysis
      • 13.7.2.1. Introduction
      • 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.2.2.1. By Product
        • 13.7.2.2.2. By Indication
        • 13.7.2.2.3. By End User
    • 13.7.3. Argentina Market Analysis
      • 13.7.3.1. Introduction
      • 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.3.2.1. By Product
        • 13.7.3.2.2. By Indication
        • 13.7.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. Germany Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.1.2.1. By Product
        • 14.7.1.2.2. By Indication
        • 14.7.1.2.3. By End User
    • 14.7.2. Italy Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.2.2.1. By Product
        • 14.7.2.2.2. By Indication
        • 14.7.2.2.3. By End User
    • 14.7.3. France Market Analysis
      • 14.7.3.1. Introduction
      • 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.3.2.1. By Product
        • 14.7.3.2.2. By Indication
        • 14.7.3.2.3. By End User
    • 14.7.4. U.K. Market Analysis
      • 14.7.4.1. Introduction
      • 14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.4.2.1. By Product
        • 14.7.4.2.2. By Indication
        • 14.7.4.2.3. By End User
    • 14.7.5. Spain Market Analysis
      • 14.7.5.1. Introduction
      • 14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.5.2.1. By Product
        • 14.7.5.2.2. By Indication
        • 14.7.5.2.3. By End User
    • 14.7.6. BENELUX Market Analysis
      • 14.7.6.1. Introduction
      • 14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.6.2.1. By Product
        • 14.7.6.2.2. By Indication
        • 14.7.6.2.3. By End User
    • 14.7.7. Russia Market Analysis
      • 14.7.7.1. Introduction
      • 14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.7.2.1. By Product
        • 14.7.7.2.2. By Indication
        • 14.7.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Product
    • 15.4.2. By Indication
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. China Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.1.2.1. By Product
        • 15.7.1.2.2. By Indication
        • 15.7.1.2.3. By End User
    • 15.7.2. Japan Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.2.2.1. By Product
        • 15.7.2.2.2. By Indication
        • 15.7.2.2.3. By End User
    • 15.7.3. South Korea Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.3.2.1. By Product
        • 15.7.3.2.2. By Indication
        • 15.7.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. India Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.1.2.1. By Product
        • 16.7.1.2.2. By Indication
        • 16.7.1.2.3. By End User
    • 16.7.2. Indonesia Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.2.2.1. By Product
        • 16.7.2.2.2. By Indication
        • 16.7.2.2.3. By End User
    • 16.7.3. Malaysia Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.3.2.1. By Product
        • 16.7.3.2.2. By Indication
        • 16.7.3.2.3. By End User
    • 16.7.4. Thailand Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.4.2.1. By Product
        • 16.7.4.2.2. By Indication
        • 16.7.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By End User
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. Australia Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.1.2.1. By Product
        • 17.7.1.2.2. By Indication
        • 17.7.1.2.3. By End User
    • 17.7.2. New Zealand Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.2.2.1. By Product
        • 17.7.2.2.2. By Indication
        • 17.7.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Product
    • 18.4.2. By Indication
    • 18.4.3. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. GCC Countries Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.1.2.1. By Product
        • 18.7.1.2.2. By Indication
        • 18.7.1.2.3. By End User
    • 18.7.2. Turkiye Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.2.2.1. By Product
        • 18.7.2.2.2. By Indication
        • 18.7.2.2.3. By End User
    • 18.7.3. South Africa Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.3.2.1. By Product
        • 18.7.3.2.2. By Indication
        • 18.7.3.2.3. By End User
    • 18.7.4. North Africa Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.4.2.1. By Product
        • 18.7.4.2.2. By Indication
        • 18.7.4.2.3. By End User

19. Market Structure Analysis

  • 19.1. Market Analysis, by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Abbott
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Product Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. Edwards Lifesciences Corporation
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
        • 20.3.2.6.1. Marketing Strategy
        • 20.3.2.6.2. Product Strategy
        • 20.3.2.6.3. Channel Strategy
    • 20.3.3. Medtronic plc
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
        • 20.3.3.6.1. Marketing Strategy
        • 20.3.3.6.2. Product Strategy
        • 20.3.3.6.3. Channel Strategy
    • 20.3.4. Boston Scientific Corporation
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
        • 20.3.4.6.1. Marketing Strategy
        • 20.3.4.6.2. Product Strategy
        • 20.3.4.6.3. Channel Strategy
    • 20.3.5. JenaValve Technology, Inc.
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
        • 20.3.5.6.1. Marketing Strategy
        • 20.3.5.6.2. Product Strategy
        • 20.3.5.6.3. Channel Strategy
    • 20.3.6. Meril Life Sciences
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
        • 20.3.6.6.1. Marketing Strategy
        • 20.3.6.6.2. Product Strategy
        • 20.3.6.6.3. Channel Strategy
    • 20.3.7. Sahajanand Medical Technologies Limited
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
        • 20.3.7.6.1. Marketing Strategy
        • 20.3.7.6.2. Product Strategy
        • 20.3.7.6.3. Channel Strategy
    • 20.3.8. MicroPort Scientific Corporation
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
        • 20.3.8.6.1. Marketing Strategy
        • 20.3.8.6.2. Product Strategy
        • 20.3.8.6.3. Channel Strategy
    • 20.3.9. Venus Medtech (Hangzhou) Inc.
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Key Financials
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategy Overview
        • 20.3.9.6.1. Marketing Strategy
        • 20.3.9.6.2. Product Strategy
        • 20.3.9.6.3. Channel Strategy
    • 20.3.10. Suzhou Jiecheng Medical Technology Co. Ltd.
      • 20.3.10.1. Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Sales Footprint
      • 20.3.10.4. Key Financials
      • 20.3.10.5. SWOT Analysis
      • 20.3.10.6. Strategy Overview
        • 20.3.10.6.1. Marketing Strategy
        • 20.3.10.6.2. Product Strategy
        • 20.3.10.6.3. Channel Strategy
    • 20.3.11. Peijia Medical Limited
      • 20.3.11.1. Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Sales Footprint
      • 20.3.11.4. Key Financials
      • 20.3.11.5. SWOT Analysis
      • 20.3.11.6. Strategy Overview
        • 20.3.11.6.1. Marketing Strategy
        • 20.3.11.6.2. Product Strategy
        • 20.3.11.6.3. Channel Strategy
    • 20.3.12. Blue Sail Medical Co., Ltd.
      • 20.3.12.1. Overview
      • 20.3.12.2. Product Portfolio
      • 20.3.12.3. Sales Footprint
      • 20.3.12.4. Key Financials
      • 20.3.12.5. SWOT Analysis
      • 20.3.12.6. Strategy Overview
        • 20.3.12.6.1. Marketing Strategy
        • 20.3.12.6.2. Product Strategy
        • 20.3.12.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology